GUTproject: Evaluation of the Lymphocyte Subpopulations in the Normal Mucosa of the Upper Digestive Tract

Sponsor

Hospital Mutua de Terrassa (Other)

Overall Status

Recruiting

CT.gov ID

NCT05084807

Collaborator

(none)

Enrollment

Location

Arm

Anticipated Duration (Months)

1.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The macro and microscopic findings of the upper gastrointestinal tract are useful in the differential diagnosis of digestive diseases such as Crohn's or celiac diseases. However, the histopathological findings (duodenal lymphocytosis, atrophy, chronic inflammatory infiltrate, etc.) are generally not pathognomonic, and there is a great overlap between different inflammatory diseases. The study of lymphocyte subpopulations of the intestine has shown its usefulness in cases of celiac disease that are difficult to diagnose. In patients with celiac disease, lymphocytes that infiltrate the duodenum present a specific pattern with increased percentage of TCRgẟ+ lymphocytes and reduced percentage of CD3- lymphocytes. However, it is currently unknown if other inflammatory diseases (e.g. Crohn's disease) have specific lymphocyte subpopulations that could be of great diagnostic aid. One of the main problems in establishing patterns associated with disease is the absence of immunological studies carried out in healthy individuals. Most of the studies include, as a control group, patients who undergo gastroscopy for the study of upper digestive symptoms and have microscopically normal duodenal biopsy. This is a heterogeneous population that includes, among others, patients with functional pathology in whom the existence of low-grade inflammatory phenomena has been suggested. Therefore, patients with digestive symptoms are not good controls to establish normal patterns of intestinal immunity.

Condition or Disease	Intervention/Treatment	Phase
Lymphocytic Enteritis (Disorder) Healthy Volunteers	Other: Endoscopy	N/A

Detailed Description

Hypothesis: The evaluation of the lymphocyte subpopulations of the subjects without digestive symptoms and normal upper digestive tract mucosa will allow to have a healthy control group with which to compare the cellular patterns of different chronic inflammatory diseases.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

20 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Intervention Model Description:

Study Type: descriptive cross-sectional study, prospective. Estimated enrollment: 20 individuals. Estimated duration of the project: 12 months.Study Type: descriptive cross-sectional study, prospective. Estimated enrollment: 20 individuals. Estimated duration of the project: 12 months.

Masking:

None (Open Label)

Primary Purpose:

Basic Science

Official Title:

Evaluation of the Lymphocyte Subpopulations in the Normal Mucosa of the Upper Digestive Tract

Actual Study Start Date :

Jun 1, 2021

Anticipated Primary Completion Date :

Jun 1, 2022

Anticipated Study Completion Date :

Dec 31, 2022

Arms and Interventions

Arm	Intervention/Treatment
Other: Healthy group A group of healthy, strictly asymptomatic individuals of both sexes and different age groups.	Other: Endoscopy A dyspepsia test will be performed to avoid selection bias. In subjects strictly asymptomatic, a blood analysis will be proposed. Subjects who present strictly normal laboratory tests (including celiac serology and negative H Pylori tests) and no genetic risk of celiac disease will be invited to perform an upper gastrointestinal endoscopy. During gastroscopy, samples of normal mucosa will be taken for histological and lymphocyte subpopulations analysis. The percentage of lymphocyte subpopulations will be assessed by flow cytometry. To compare whether there are differences between the lymphocyte subpopulations related to the age and sex of the healthy individuals, a student's t test, ANOVA or the corresponding non-parametric test will be used. The values will be expressed according to: mean +/- 2DS or median and interquartile range.

Arm

Intervention/Treatment

Other: Healthy group

A group of healthy, strictly asymptomatic individuals of both sexes and different age groups.

Other: Endoscopy

A dyspepsia test will be performed to avoid selection bias. In subjects strictly asymptomatic, a blood analysis will be proposed. Subjects who present strictly normal laboratory tests (including celiac serology and negative H Pylori tests) and no genetic risk of celiac disease will be invited to perform an upper gastrointestinal endoscopy. During gastroscopy, samples of normal mucosa will be taken for histological and lymphocyte subpopulations analysis. The percentage of lymphocyte subpopulations will be assessed by flow cytometry. To compare whether there are differences between the lymphocyte subpopulations related to the age and sex of the healthy individuals, a student's t test, ANOVA or the corresponding non-parametric test will be used. The values will be expressed according to: mean +/- 2DS or median and interquartile range.

Outcome Measures

Primary Outcome Measures

Percentage of the lymphocyte subpopulations of the upper digestive tract as assessed by flow cytometry in asymptomatic healthy subjects with normal mucosa. [4 hour]
During gastroscopy, samples of normal mucosa will be taken for histological and lymphocyte subpopulations analysis. The percentage of lymphocyte subpopulations will be assessed by flow cytometry.

Secondary Outcome Measures

Comparison the percentage of the pattern of lymphocyte subpopulations in the duodenum in relation to age and sex. [4 hour]
To compare whether there are differences between the lymphocyte subpopulations related to the age and sex of the healthy individuals, a student's t test, ANOVA or the corresponding non-parametric test will be used. The values will be expressed according to: mean +/- 2DS or median and interquartile range.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Study population: 20 healthy individuals, strictly asymptomatic, of both sexes, in different age groups will be included.

Inclusion Criteria:

Adult individuals without any comorbidity, strictly asymptomatic.
Age> 18 years.
Informed consent signature.
Carrying out a varied, non-restrictive diet.
Negative blood tests including celiac serology, H. pylori serology and celiac disease genetic study (will only be accepted if they have positive DQ2.2 allele).
Normal esophagogastroduodenoscopy.
Grossly and microscopic normal duodenal mucosa.

Exclusion Criteria:

Refusal of the individual to participate.
Severe disease (heart disease, lung disease, liver disease, bleeding disorders, neoplasms, etc.).
Personal history of celiac disease and / or inflammatory bowel disease.
Pregnancy and/or lactation.
Age> 45 years.
BMI> 28.
Presence of any current digestive symptoms (negative responses must be met in all items of the dyspepsia test).
Family history of 1st or 2nd degree of celiac disease or inflammatory bowel disease.
Potentially contagious diseases (HIV, HCV, HBV, tuberculosis, Covid19, ...).
Trips to tropical countries in the last 6 months.
Presence of coagulopathy or use of anticoagulant treatments.
Consumption of any drug (including NSAIDs) in the last 4 weeks.
Strict vegetarian, vegan or gluten-free diet.
1. pylori positive.
DQ2.5 positive and /or DQ8 positive
Positive celiac serology (anti-transglutaminase> 2 U / mL).
Active smoking.
Habitual alcohol intake >40 g in men and 20 g in women.
Alcohol intake in the previous 3 days.
Esophagus-gastro-duodenoscopy with macroscopically abnormal mucosa.